Compare ADAG & ALCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ADAG | ALCO |
|---|---|---|
| Founded | 2011 | 1960 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 260.3M | 305.0M |
| IPO Year | 2020 | 1994 |
| Metric | ADAG | ALCO |
|---|---|---|
| Price | $3.30 | $39.10 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | $8.25 | ★ $44.00 |
| AVG Volume (30 Days) | ★ 310.1K | 18.5K |
| Earning Date | 04-01-2026 | 05-11-2026 |
| Dividend Yield | N/A | ★ 0.49% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.03 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $37.98 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.44 | $31.32 |
| 52 Week High | $4.85 | $45.01 |
| Indicator | ADAG | ALCO |
|---|---|---|
| Relative Strength Index (RSI) | 36.27 | 28.52 |
| Support Level | $2.78 | $37.19 |
| Resistance Level | $3.53 | $42.13 |
| Average True Range (ATR) | 0.33 | 0.77 |
| MACD | -0.07 | -0.28 |
| Stochastic Oscillator | 7.07 | 10.55 |
Adagene Inc is a platform-driven, clinical-stage biotechnology company focused on the discovery and development of novel antibody-based cancer immunotherapies. The Company leverages computational biology to design and develop novel antibodies. Powered by its Dynamic Precision Library (DPL) platform, which fuels its NEObody, SAFEbody, and POWERbody technologies, it is developing a pipeline of immunotherapies. Its candidate, ADG126 (muzastotug), an anti-CTLA-4 SAFEbody, is in phase 1b/2 and phase 2 clinical development for metastatic microsatellite-stable colorectal cancer. Its clinical-stage products include ADG126 and ADG116, investigational fully human anti-CTLA-4 mAbs generated through SAFEbody and NEObody technologies.
Alico Inc is a Florida-based agribusiness and land management company that mainly focuses on citrus production and grove conservation. The company operates through two primary business units: Alico Citrus and Land Management and Other Operations. The Alico Citrus segment engages in the cultivation of citrus trees and delivers citrus to the processed and fresh citrus markets. It mainly serves the processed market and sells Hamlin oranges and the Valencia variety to the orange juice processors. The Land Management and Other Operations segment engages in land leasing for recreational, conservation, and mining activities. Alico Citrus delivers the majority of the revenue as the firm's primary operating business unit.